Biotech startup Exsure has raised Rs 3 crore in a funding round led by Unicorn India Ventures to advance its exosomal drug-delivery platform for anti-cancer treatments. The funds will support Exsure's ...

Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...

Selective stock-picking and conviction drove HB Biotech’s strong 2024 performance. Read our insights on navigating today’s ...

"We see this being particularly useful for devices that don't need the extreme precision of silicon chips but still require ...

The Trump administration is bringing new instability to a sector already grappling with a shaky market as well as threats ...

With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.

OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to ...

An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.

Scientists led by a Macquarie University team have completed construction of the final chromosome in the worlds’ first synthetic yeast genome following more than a decade of work, opening new ...

Binance Labs has been rebranded to YZi Labs to reflect its autonomy and expanded investment focus which now includes Web3, artificial ...

Speaking at an inauguration eve rally in Washington, Trump claimed that the forthcoming pardons would make his supporters ...